EMPLOYMENT AGREEMENTEmployment Agreement • June 3rd, 2024 • Rapport Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made between Rapport Therapeutics, Inc., a Delaware corporation (the “Company”), and Abraham N. Ceesay (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Offer Letter between the Executive and the Company dated December 12, 2022 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.
RAPPORT THERAPEUTICS, INC. FORM OF EMPLOYEE DIRECTOR / OFFICER INDEMNIFICATION AGREEMENTIndemnification Agreement • June 3rd, 2024 • Rapport Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [•], 2024, by and between Rapport Therapeutics, Inc., a Delaware corporation (the “Company”), and [Name] (“Indemnitee”).
Rapport Therapeutics, Inc. Common Stock, par value $0.001 per share Underwriting AgreementUnderwriting Agreement • June 3rd, 2024 • Rapport Therapeutics, Inc. • Pharmaceutical preparations
